The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Synlogic, Inc(NASDAQ:SYBX) 
Synlogic, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of synthetic biotic medicines to treat metabolic, inflammatory, and cancer diseases in the United States. Its therapeutic programs include SYNB1618, an oral therapy that is in Phase II clinical trial...
Website: http://www.synlogictx.com
Founded: 2014
Full Time Employees: 76
Sector: Healthcare
Industry: Biotechnology
Synlogic Days Payable Outstanding ttm (DPO)
Synlogic Days Receivable Outstanding ttm (DSO)
Synlogic Op Cashflow Per Share ttm
Synlogic Free Cashflow Per Share ttm
Synlogic Cash Per Share ttm
Synlogic P/S ratio ttm
Synlogic (GAAP) P/E ratio ttm
Synlogic P/B ratio ttm
No extra charts and metrics for this ticker.